Gland Pharma receives USFDA approval for Eribulin Mesylate Injection
The Product is expected to be the first generic approval on the market
The Product is expected to be the first generic approval on the market
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
Subscribe To Our Newsletter & Stay Updated